Kelvin Chu

Since joining Kirkland, Kelvin has advised on the following:

• Alphamab Oncology (HKSE: 09966), a leading China-based biopharmaceutical company, on the raising of approximately HK$380.5 million by way of top-up placing of 25 million existing shares and issuing the same amount of shares under general mandate
• Vision Deal HK Acquisition Corp., a special purpose acquisition company (SPAC), on its listing of shares (HKSE: 7827) and warrants (HKSE: 4827) on the Hong Kong Stock Exchange on June 10, 2022. This marks the second Hong Kong SPAC listing, the first Hong Kong SPAC listing led by promoters with substantial entrepreneurial and private equity background, and the largest Hong Kong SPAC listing by offering size at the time of listing 
• Jiangsu Recbio Technology Co., Ltd. (HKSE: 2179), a vaccine company dedicated to the research, development and commercialization of subunit vaccines, on its global offering and listing of H-shares on the Hong Kong Exchanges and Clearing Limited on March 31, 2022 ‒ the first HPV vaccine stock in Hong Kong 

Prior to joining Kirkland, Kelvin has advised on the following:

Initial Public Offerings

• China Bohai Bank Co., Ltd. in connection with its US$1.78 billion global offering and listing of its H shares on the Main Board of the Hong Kong Stock Exchange. China Bohai Bank is a nationwide joint-stock commercial bank in the PRC
• The joint sponsors and underwriters in the US$331 million global offering and listing of Radiance Holdings (Group) Company Limited on the Main Board of the Hong Kong Stock Exchange. Radiance Holdings is a PRC property developer having national presence
• The joint sponsors and underwriters in the US$97 million global offering and listing of Weimob Inc. on the Main Board of Hong Kong Stock Exchange. Weimob is principally engaged in provision of cloud-based commerce and marketing solutions and targeted marketing services on Tencent’s social networking service platforms for merchants in China
• Midea Real Estate Holding Limited in connection with its US$392 million global offering and listing of its shares on the Main Board of Hong Kong Stock Exchange. Midea Real Estate is a large renowned national property developer in the PRC
• Shandong Gold Mining Co., Ltd., an A-share listed company, in connection with its US$594 million global offering and listing of H shares on the Main Board of the Hong Kong Stock Exchange. Shandong Gold is engaged in the mining and smelting of gold
• The joint sponsors and underwriters in the US$1.07 billion global offering and listing of H shares of Guangzhou Rural Commercial Bank Co., Ltd. on the Main Board of the Hong Kong Stock Exchange. Guangzhou Rural Commercial Bank is one of the leading rural commercial banks in the PRC
• Genscript Biotech Corporation in connection with its US$77 million global offering and listing of its shares on the Main Board of the Hong Kong Stock Exchange. Genscript Biotech is a biotech company principally engaged in the manufacture and sale of life science research products and services
• The sole sponsor and underwriters in the public offering and placing of Yuk Wing Group Holdings Limited and listing of its shares on the Main Board of the Hong Kong Stock Exchange
• Chun Sing Engineering Holdings Limited in connection with its share offer and listing of its shares on the Main Board of the Stock Exchange
• Ngai Shun Holdings Limited in connection with its share offer and listing of its shares on the Main Board of the Stock Exchange
• Jin Cai Holdings Limited in connection with its share offer and listing of its shares on the Main Board of the Stock Exchange
• Sunley Holdings Limited in connection with its share offer and listing of its shares on the Main Board of the Stock Exchange
• Finsoft Corporation in connection with its placing and listing of its shares on the GEM of the Stock Exchange

M&A and Other Corporate Finance Transactions

• Liaoning Port Co., Ltd., an A/H share company, on its merger by adsorption with Yingkou Port Liability Co., Ltd, an A-share company. The merger was one of the vital steps of port integration in Liaoning Province, the PRC
• Simcere Pharmaceutical on its Series B investment in a precision diagnostic company
• HOPU Investment in connection with its US$87 million share subscription in Shoucheng Holdings Limited, a company listed on the Main Board of the Hong Kong Stock Exchange
• Shanghai Dasheng Agriculture Finance Technology Co., Ltd. in connection with its US$208 million domestic shares subscription and H shares placing involving application for whitewash waiver by the then existing substantial shareholder
• Shanghai Dasheng Agriculture Finance Technology Co., Ltd. in connection with its US$63 million domestic shares and H shares rights issue pursuant to specific mandate
• COFCO in connection with its joint venture on a commercial property development project with Government of Singapore Investment Corporation (GIC)
• China CBM Group Company Limited in connection with its US$16 million open offer

Post-Listing Compliance Matters

• Advised more than 15 listed issuers on the Hong Kong Stock Exchange (comprising A/H share issuers, domestic/H share issuers and red-chip issuers) on various post-listing compliance matters, including notifiable and connected transactions, equity and debt securities offering, capital reorganization, share incentive scheme and Takeovers Code related matters